Latest news
Vanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia - StocktwitsStocktwits · Fri, 07 Aug 2026 04:34:06 GMTAXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug This Week - StocktwitsStocktwits · Fri, 07 Aug 2026 00:45:37 GMTmFLUSIVA Approved: FDA Clears mRNA Flu Shot, Unlocking Combo and Pandemic Vaccine Resubmission - Tech TimesTech Times · Thu, 06 Aug 2026 12:17:21 GMTModerna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 03:36:50 GMTReacting to the FDA Advisory Committee Verdict on RP1 in Melanoma - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 19:00:00 GMTmRNA Flu Vaccine Faces FDA Verdict: Approval Alone Won’t Mean Coverage for Seniors - Tech TimesTech Times · Wed, 05 Aug 2026 13:23:56 GMTReplimune’s Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, ‘High Conviction’ For Approval - TradingViewTradingView · Tue, 04 Aug 2026 10:44:37 GMTInovio banks $20 million to steady itself before October FDA verdict - The Pharma LetterThe Pharma Letter · Thu, 30 Jul 2026 13:17:50 GMT